Analysts delivered a mixed bag of ratings Monday, with upgrades in financials and biotech offset by cuts in energy and consumer staples.
MRNA grabbed attention with a fresh upgrade. The consensus rating improved as one analyst moved from sell to hold. The average target price edged up to $49.37. Short interest sits at 14.4% of free float — high for a large-cap biotech — making any bullish shift notable.
Fertilizer giant CF moved the other way. One analyst cut the stock, pulling the consensus hold count from 12 to 13. The downgrade comes as nitrogen prices remain under pressure from cheap imports. Short interest is modest at 6.8% of FF, but the analyst community is growing cautious.
In banking, USB — U.S. Bancorp — earned an upgrade. The consensus flipped from one sell to zero, with 13 holds now in the mix. The $70 average target implies room to run from current levels. Earnings beats across regional banks have been fueling this sector's positive momentum.
Domino's Pizza saw its average target trimmed to $387, down from $391. Analysts remain split — 17 sells against just one buy — a notably bearish skew for a consumer brand.
W. R. Berkley collected two separate target price raises in quick succession, pushing consensus toward a firmer buy tilt with seven buy ratings now on record.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
